Asset Details
Do you wish to reserve the book?
Estimating Direct and Indirect Costs of Premenstrual Syndrome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Estimating Direct and Indirect Costs of Premenstrual Syndrome
Do you wish to request the book?
Estimating Direct and Indirect Costs of Premenstrual Syndrome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Estimating Direct and Indirect Costs of Premenstrual Syndrome
2005
Overview
Objective: To quantify the economic impact of premenstrual syndrome (PMS) on the employer. Methods: Data were collected from 374 women aged 18-45 with regular menses. Direct costs were quantified using administrative claims of these patients and the Medicare Fee Schedule. Indirect costs were quantified by both self-reported days of work missed and lost productivity at work. Regression analyses were used to develop a model to project PMS-related direct and indirect costs. Results: A total of 29.6% (n = 111) of the participants were diagnosed with PMS. A PMS diagnosis was associated with an average annual increase of $59 in direct costs (P < 0.026) and $4333 in indirect costs per patient (P < 0.0001) compared with patients without PMS. Conclusions: A PMS diagnosis correlated with a modest increase in direct medical costs and a large increase in indirect costs.
Publisher
Lippincott Williams & Wilkins,The American College of Occupational and Environmental Medicine
